# Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

> **NCT01050634** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 980 (actual)

## Conditions studied

- Post Menopausal Women With Early Breast Cancer

## Interventions

- **DRUG:** Aromasin (exemestane)

## Key facts

- **NCT ID:** NCT01050634
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 980 (ACTUAL)
- **Last updated:** 2010-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050634, "Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01050634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*